May 10th 2024
A recent study reveals associations between concomitant histological fetal inflammatory response and adverse neonatal outcomes, urging further investigation into implications.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Pitocin in late stage labor for reduction of obstetrical hemorrhage
September 13th 2023Study authors from a poster highlighted at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting suggest that implementing a standardized oxytocin infusion protocol may increase patient safety, while simultaneously reducing the rate of postpartum hemorrhage.
Read More
Implementing advanced fetal heart rate monitoring interpretation into your practice
September 12th 2023Sean Esplin, MD, maternal-fetal medicine physician, senior medical director for women’s health, professor, Department of OB/GYN, University of Utah, discusses his presentation on advanced fetal heart rate monitoring interpretation at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.
Watch
Recognizing the importance of aesthetics in cesarean section closures
September 12th 2023In a poster featured at the 2023 Society for OB/GYN Hospitalists Annual Clinical Meeting, study investigators underline the importance of aesthetics in cesarean section closures as both providers and patients.
Read More
Model developed for predicting postpartum hemorrhage
August 28th 2023In a recent study, the most effective model for predicting postpartum hemorrhage in patients with pernicious placenta previa used a logical least absolute shrinkage and selection operator adopting risk factors of ultrasound and magnetic resonance imaging.
Read More
FDA approves Pfizer’s maternal vaccine to prevent RSV in infants
August 22nd 2023Approved for use at 32 weeks through 36 weeks gestation, Pfizer’s maternal respiratory syncytial vaccine (Abrysvo), is delivered through a single dose injection to the muscle, and is the first vaccine for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD because of RSV in infants (birth to 6 months).
Read More